Atlas Trials

Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study

Clinical trial NCT04431895 · COMPLETED

Trial details

NCT number
NCT04431895
Sponsor
Huashan Hospital
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Myasthenia Gravis, Generalized
Start date
2020-06-11
Primary completion
2024-03-21
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.